Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;36(11):3307-3310.
doi: 10.1007/s11606-020-06540-4. Epub 2021 Feb 5.

Post-Visit Patient Understanding About Newly Prescribed Medications

Affiliations

Post-Visit Patient Understanding About Newly Prescribed Medications

Timothy Ho et al. J Gen Intern Med. 2021 Nov.

Abstract

Background: Good patient understanding of basic medication-related information such as directions for use and side effects promotes medication adherence, but information is lacking about how well patients understand basic medication-related information after their office visits.

Objective: The purpose of this study is to investigate post-visit patient understanding about newly prescribed medications.

Design: Secondary mixed methods analysis comparing patient survey responses about newly prescribed medications to information conveyed by physicians during office visits (from audio recordings of office visits).

Participants: Eighty-one patients aged 50 and older who discussed newly prescribed medications during an outpatient office visit.

Main measures: Accurate patient identification of medication dose, number of pills, frequency of use, duration of use, and potential side effects.

Key results: The 81 patients in this study received 111 newly prescribed medications. For over 70% of all newly prescribed medications, patients correctly identified the number of pills, frequency of use, duration of use, and dose, regardless of whether the physician mentioned the information during the office visit. However, for 34 of 62 medications (55%) for which side effects were not conveyed and 11 of 49 medications (22%) for which physicians discussed side effects, patients reported that the medication lacked side effects. Analysis of transcribed office visits showed that potential reasons for this finding included failure of physicians to mention or to use the term "side effects" during visits, the prescription of multiple medications during the visit, and lack of patient engagement in the conversation.

Conclusions: Many patients correctly identified information related to directions for taking a newly prescribed medication, even without physician counseling, but when physicians failed to convey potential medication side effects, many assumed that a medication had no side effects. It may be sufficient for physicians to provide written information about medication directions and dosing, and tailor their limited time to discussing medication side effects.

Keywords: adverse effects; mixed methods research; physician-patient relations; prescription medications.

PubMed Disclaimer

Conflict of interest statement

Dr. Tarn has been funded by the BMS/Pfizer Alliance ARISTA-USA to conduct unrelated research studies. Mr. Ho and Dr. Campos have no conflicts of interest.

Figures

Figure 1
Figure 1
Frequency with which patients recalled information regarding newly prescribed medications immediately post-visit, by whether physicians mentioned the information during the office visit, n = 111 medications. Blue bars indicate accurate patient report of physician discussion; red bars indicate accurate patient report but lack of physician discussion; yellow bars indicate inaccurate patient report of physician discussion; and green bars indicate inaccurate patient report with lack of physician discussion. Dotted bars for side effects indicate that the patient reported the medication had “no side effects.”

Similar articles

Cited by

References

    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. doi: 10.1056/NEJMra050100. - DOI - PubMed
    1. Walsh CA, Cahir C, Tecklenborg S, Byrne C, Culbertson MA, Bennett KE. The association between medication non-adherence and adverse health outcomes in ageing populations: a systematic review and meta-analysis. Br J Clin Pharmacol. 2019;85:2464–2478. doi: 10.1111/bcp.14075. - DOI - PMC - PubMed
    1. Gellad WF, Grenard J, McGlynn EA. A review of barriers to medication adherence: a framework for driving policy options. 2009. Available at: http://www.rand.org/content/dam/rand/pubs/technical_reports/2009/RAND_TR.... Accessed July 8 2020.
    1. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166:1855–1862. doi: 10.1001/archinte.166.17.1855. - DOI - PubMed
    1. Tarn DM, Paterniti DA, Heritage J, Hays RD, Kravitz RL, Wenger NS. Physician communication about the cost and acquisition of newly prescribed medications. Am J Manag Care. 2006;12(11):657–664. - PubMed

Publication types